SCHEMBL9731004

SCHEMBL9731004

NC(=O)N(C(=O)c1ccccc1)C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 2/20 0.45
POLB P06746 2/20 0.45
TSHR P16473 2/20 0.45
CYP2C19 P33261 2/20 0.45
TDP1 Q9NUW8 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
CYP3A4 P08684 1/20 0.45
PARP1 P09874 1/20 0.45
MAPT P10636 1/20 0.45
RECQL P46063 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
HSD17B10 Q99714 1/20 0.45
NR1H3 Q13133 2/20 0.41
NR1H2 P55055 1/20 0.41
MLYCD O95822 1/20 0.41
TRPM8 Q7Z2W7 2/20 0.38
ALDH1A1 P00352 2/20 0.38
DAO P14920 1/20 0.38
NAPRT Q6XQN6 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27774491 0.88 CES1 (0.52) CES1POLBTSHRCYP2C19TDP1
Hydrochloric Acid SCHEMBL27397319 0.84 BLM (0.44) CES1POLBTSHRCYP2C19TDP1
SCHEMBL28013544 0.78 CES1 (0.39) CES1POLBTSHRCYP2C19TDP1
SCHEMBL2481566 0.76 CES1 (0.48) CES1POLBTSHRCYP2C19TDP1
SCHEMBL1601291 0.75 CES1 (0.52) CES1POLBTSHRCYP2C19TDP1
SCHEMBL28013534 0.74 SMN1; SMN2 (0.46) CES1POLBCYP2C19TDP1L3MBTL1
Hydrochloric Acid SCHEMBL6506892 0.74 CES1 (0.50) CES1POLBTSHRCYP2C19TDP1
SCHEMBL7202702 0.74 TSHR (0.50) CES1POLBTSHRCYP2C19TDP1
SCHEMBL4125957 0.73 TDP1 (0.54) CES1POLBTSHRCYP2C19TDP1
SCHEMBL28928425 0.72 CES1 (0.48) CES1POLBTSHRCYP2C19TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5106843-A Treatment of migraine, emesis, anxiety, gastrointestinal disorders, psychological disorders AMERICAN HOME PRODUCTS CORPORATION (US) 1992-04-21 US disclosed
EP-0323077-B1 HETEROCYCLIC COMPOUNDS JOHN WYETH & BROTHER LIMITED (GB) 1991-09-11 EP disclosed
US-4983600-A Antiemetics, antianxiety agents, gastrointestinal disorders JOHN WYETH & BROTHER LIMITED (GB) 1991-01-08 US disclosed
EP-0323077-A1 Heterocyclic compounds JOHN WYETH & BROTHER LIMITED (GB) 1989-07-05 EP disclosed
EP-0030518-A1 Substituted N-3-trifluoromethyl-N-benzoyl ureas, process for their preparation, compositions containing these compounds and their use in combating pests CIBA-GEIGY AG (CH) 1981-06-17 EP disclosed